Ludwig Enterprises, Inc. (LUDG)
OTCMKTS · Delayed Price · Currency is USD
0.0470
0.00 (0.00%)
Oct 29, 2025, 4:00 PM EDT
Ludwig Enterprises Revenue
Ludwig Enterprises had revenue of $207.00 in the twelve months ending June 30, 2025, up 1,970.00% year-over-year. In the year 2024, Ludwig Enterprises had annual revenue of $217.00.
Revenue (ttm)
207.00
Revenue Growth
+1,970.00%
P/S Ratio
36,527.94
Revenue / Employee
69.00
Employees
3
Market Cap
7.56M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 217.00 | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2012 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2011 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2010 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2009 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2008 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| American Oncology Network | 1.76B |
| Veradigm | 588.02M |
| Jushi Holdings | 256.36M |
| Glass House Brands | 221.55M |
| Elite Pharmaceuticals | 105.45M |
| Silence Therapeutics | 27.17M |
| Nuo Therapeutics | 1.95M |
| Northwest Biotherapeutics | 1.09M |
Ludwig Enterprises News
- 5 months ago - Ludwig Enterprises Announces Publication of ASCO Abstract Detailing Novel Non-Invasive mRNA Signals that Scan for Breast Cancer - Accesswire
- 6 months ago - Revealia Breast(TM) Offers Glimpse Into the Future of Early Cancer Detection With a Simple Cheek Swab - Accesswire
- 6 months ago - Ludwig Enterprises Announces Two Abstracts Accepted for Publication in the Journal of Clinical Oncology - Accesswire
- 6 months ago - Ludwig Enterprises Inc. Announces New Leadership Appointment of Charles T. Todd, Jr. - Accesswire
- 1 year ago - Ludwig Enterprises Begins PCR Validation Test Process - Accesswire
- 1 year ago - Ludwig Enterprises Files Provisional Patent for Revolutionary Cancer Screening Algorithm, Plans 2024 Launch as Revealia(TM) - Accesswire
- 1 year ago - CORRECTING AND REPLACING: Ludwig Enterprises Inc. Announces AI-Powered Cancer Screening Technology - Accesswire
- 1 year ago - Ludwig Enterprises Inc. Announces AI-Powered Cancer Screening Technology - Accesswire